Lv0
0 积分 2025-12-19 加入
Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapy
1个月前
已完结
Olink Proteomics-Based Exploration of Immuno-Oncology-Related Biomarkers Leading to Lung Adenocarcinoma Progression
5个月前
已完结
A TNFR2–hnRNPK Axis Promotes Primary Liver Cancer Development via Activation of YAP Signaling in Hepatic Progenitor Cells
6个月前
已完结
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
7个月前
已完结
Novel Three-Dimensional Hierarchical Porous Carbon Probe for the Discovery of N-Glycan Biomarkers and Early Hepatocellular Carcinoma Detection
9个月前
已完结
Recurrence in Patients With Lymph Node-Negative Pancreatic Neuroendocrine Tumors
9个月前
已完结
Follow-Up for Node-Negative Patients After Resection for Pancreatic Neuroendocrine Tumor
9个月前
已关闭
Recurrence in Patients With Lymph Node-Negative Pancreatic Neuroendocrine Tumors
9个月前
已完结
Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial
10个月前
已完结
Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti–PD-1 Immune Checkpoint Inhibitors
10个月前
已完结
皖公网安备34019202002308
